Detection of minimal residual disease in acute leukemia by flow cytometry.
about
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligandsMyeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigensHow frequently are predicted peptides actually recognized by CD8 cells?Current Strategies for the Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaImmaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection.A new method for high speed, sensitive detection of minimal residual disease.Automated in-silico detection of cell populations in flow cytometry readouts and its application to leukemia disease monitoring.Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemiaRelationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia.Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation.Immunologic minimal residual disease detection in acute lymphoblastic leukemia: a comparative approach to molecular testingPrognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemiaSurvival of B lineage leukemic cells: signals from the bone marrow microenvironment.Assessing minimal residual disease (MRD) in leukemia: a changing definition and concept?Technical issues: flow cytometry and rare event analysis.Reliable, accurate determination of the leukocyte differential of leukopenic samples by using Hematoflow method.The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemiaMultidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia.Pathology of porcine peripheral white blood cells during infection with African swine fever virusA new method for evaluating the risk of transferring leukemic cells with transplanted cryopreserved ovarian tissue.Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia.Flow-cytometric immunophenotyping of normal and malignant lymphocytes.Measurements of treatment response in childhood acute leukemia.Methods of minimal residual disease (MRD) detection in childhood haematological malignancies.Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study.Minimal residual disease in acute lymphoblastic leukemiaPrognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemiaStatus of minimal residual disease testing in childhood haematological malignanciesRole of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia.How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.Automated analysis of acute myeloid leukemia minimal residual disease using a support vector machine.Personalised treatment of haematological malignancies through systems medicine based on single molecules in single cells.Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches.Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry.Immunophenotyping by Multiparameter Flow Cytometry.Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?Minimal residual disease detection using flow cytometry: Applications in acute leukemia.CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
P2860
Q24655544-3194DA5C-9F96-4CE8-ABBC-FC71EA5E4934Q24803325-846EAA43-EE6D-4F57-8CCF-FF0C47EF11DEQ26750788-4B53E000-F737-48D9-B893-451FAECF7D56Q26751269-911D4FF6-076A-4343-B517-A522C04F4E4AQ30432481-E145BA8F-1BE7-47FB-81D3-11B35A772EF9Q31030896-45676203-35CA-4E4C-8ABE-94AA80E4990DQ33245733-8F49458B-D29D-456F-BE2B-382DE69C817CQ33853441-37E02F44-42CF-454B-BF14-5C067388EA06Q33886177-A6E3CE23-72A5-4D6B-83AB-B23E75E644FAQ34135330-D7C1F0D4-3D78-414E-80B7-BCBD2F078745Q34425875-FAF6FE01-8BB7-4095-A98B-C49F404D5562Q34449151-21F4FE5B-4680-4F51-8E80-E932AD396850Q34573970-2080B1CE-2A87-4BB3-A3E3-D282BFB28B76Q34605187-D7BA435B-41CE-4D10-BA5D-7D270A97B92BQ34670653-4A8FB194-DD4D-4C6C-9343-2508585A04A5Q35085493-0AE86F7C-899E-498A-A7FC-6D82936572D1Q35094049-A5F99D13-CD03-462E-B8B2-EB9A8E74DF8DQ35104356-3E5CEED7-0FC9-4E45-9B3E-C23D098BD1BDQ35842335-5D480A52-62DE-4905-AEF3-0E8B7EA7D5B8Q36010255-CC3824BF-EC07-4FEC-BB16-77F9EF713C0BQ36366977-D09BEAF5-3764-4453-BB37-5889EDD12C72Q36425440-25D919E7-D15D-48BE-B579-050E06E4AD01Q36507615-DA98AB72-B1DF-4CE8-84AD-0A20B3579B47Q36513773-10BB2E89-245F-4C93-9C24-2DAFA52D19C7Q36726108-23618967-97C5-4ED4-AEEC-8D0D31908A76Q36750463-F88DA32C-5087-477F-950B-742C4E4CA234Q37077352-4F6E3E96-ECB6-47C0-A295-3003D879B824Q37148110-E1E202EE-CF47-4B80-AE4C-230B5D410C46Q37246360-1C51EADE-1F96-4DC6-AEC3-6E32C90D4851Q37389544-4757ECC2-EC87-45FD-BA10-3328D984195BQ37545067-CE24611C-8FD2-4528-BB54-4D948BE24808Q37687740-811BECCB-507E-426A-B532-D961120C62F7Q38093422-F97AE2D3-0321-4F6F-80AE-26E694452852Q38113738-C151AAD9-C5E4-4528-89E5-EE40E7336B36Q38257363-D4DC7557-A060-4BBF-88DF-3817AFA7FCB0Q38438814-8DB31B15-4B70-492E-8155-B2F86A9D566EQ38666234-AE5792EE-3DDF-42B7-B6F9-EA042E0B4265Q38815331-4F4D33CF-FD22-47A2-95EF-441B485762D8Q38852472-41914C41-41E6-4AC9-AC5E-24368B258F24Q38889598-36178A02-2DBA-4E78-A06F-4D728CA4C906
P2860
Detection of minimal residual disease in acute leukemia by flow cytometry.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Detection of minimal residual disease in acute leukemia by flow cytometry.
@ast
Detection of minimal residual disease in acute leukemia by flow cytometry.
@en
type
label
Detection of minimal residual disease in acute leukemia by flow cytometry.
@ast
Detection of minimal residual disease in acute leukemia by flow cytometry.
@en
prefLabel
Detection of minimal residual disease in acute leukemia by flow cytometry.
@ast
Detection of minimal residual disease in acute leukemia by flow cytometry.
@en
P2860
P1433
P1476
Detection of minimal residual disease in acute leukemia by flow cytometry.
@en
P2093
Coustan-Smith E
P2860
P304
P356
10.1002/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO;2-H
P577
1999-08-01T00:00:00Z